Neurogene Inc. (NGNE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Neurogene Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.83x | -5.34x | -6.84x | -2.37x | -105.03x | -439.18x |
| P/B Ratio | 1.65x | 1.29x | 1.34x | 1.32x | -57.75x | 76.43x |
| P/S Ratio | 0.00x | 434.14x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | -251.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | -8930.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | -8123.7% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | -7771.4% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 16.56x | 20.84x | 8.72x | 12.74x | 6.81x | 24.66x |
| Quick Ratio | 16.56x | 20.84x | 8.72x | 12.74x | 6.64x | 24.66x |
| Leverage | ||||||
| Debt/Equity | 0.04x | 0.04x | 0.09x | 0.05x | -0.07x | 0.06x |
YoY = year-over-year change. Source: FMP..